Entact Bio Appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer
Slice of Healthcare Team
09/19/2024
Key Highlights
- Entact Bio appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer.
- Dr. Tommasi brings 30 years of drug discovery leadership across multiple therapeutic areas.
- Tommasi previously served at Dunad Therapeutics and Entasis Therapeutics, driving successful clinical outcomes.
- Entact Bio focuses on precision medicines that enhance beneficial protein function via the Encompass™ platform.
Source: Business Wire
Notable Quotes
“ We’re thrilled to welcome Ruben, who brings deep expertise in drug discovery and has a proven record in successfully advancing compounds from program inception to clinical development and regulatory approval. ”
Victoria Richon, Ph.D., CEO at Entact Bio
“ I was very attracted to the innovative modality Entact is developing as it holds tremendous potential to pursue new, undrugged targets believed to be beneficial against disease. ”
Ruben Tommasi, Ph.D., Chief Scientific Officer at Entact Bio
SoHC's Take
The appointment of Dr. Ruben Tommasi as Chief Scientific Officer marks a pivotal moment for Entact Bio. His extensive experience in drug discovery, particularly in progressing compounds through to FDA approval, will likely accelerate the development of Entact's innovative ENTAC™ medicines. With a proven track record across multiple therapeutic areas, Dr. Tommasi's leadership will strengthen the company’s ability to explore novel therapeutic targets and address diseases that current treatments cannot effectively reach. This strategic move positions Entact Bio to further expand its impact on precision medicine, potentially offering new hope to patients in underserved disease areas.
Heading
Ginkgo Bioworks Launches Protein LLM and Model API Powered by Google Cloud News Product News Read More Chris-Anne Roque Entact Bio Appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer Hiring News News Read More Chris-Anne Roque #467 – Dr. Jason Stein, Chief Medical Officer at Ingenious Med AI Healthcare Innovation Read More Windley Mathurin BioDuro-Sundia Appoints Dr. Armin Spura as New CEO Hiring News News Read More Chris-Anne Roque Northwest Urgent Care Acquires 10 Arizona Urgent Care Centers from Carbon Health M&A News News Read More Chris-Anne Roque Amino Health and Motive Launch Amino Motivate for ACO Optimization News Partnership News Read More Chris-Anne Roque
